Renal replacement therapy (kuliah S1 perawat).pptx

19
Renal replacement therapy dr. Drajat

Transcript of Renal replacement therapy (kuliah S1 perawat).pptx

Page 1: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 1/19

Renal replacement therapy

dr. Drajat

Page 2: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 2/19

Page 3: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 3/19

Page 4: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 4/19

Years Until Kidney Failure (GFR < 15 mL/min/1.73 m2)

Based on Level of GFR and Rate of GFR Decline

Level of GFR

(mL/min/1.73 m2) 

Rate of GFR Decline (mL/min/1.73 m2 per year)

10 8 6 4 2 1*

90 7.5 9.4 13 19 38 75

80 6.5 8.1 11 16 33 65

70 5.5 6.8 9.2 14 28 55

60 4.5 5.6 7.5 11 23 45

50 3.5 4.4 5.8 8.8 16 35

40 2.5 3.1 4.2 6.3 13 25

30 1.5 1.9 2.5 3.8 7.5 15

20 0.5 0.6 0.8 1.3 2.5 5

• Average age-related GFR decline after age 20-30 year 

•MDRD Study: average rate of decline in GFR is 4 ml/min/year. 85% declined,15% stabile or improvement 

Page 5: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 5/19

Page 6: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 6/19

Attemps to prevent and correct acute decline

on chronic renal failure

• Volume depletion

• IV radiographic contrast

•Antimicrobial agent (aminoglycoside,amphotericine B)

• NSAID (including Cox2)

• ACE/ARB

• Cyclosporine and tacrolimus• Obstruction of the urinary tract

Page 7: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 7/19

Interventions that have been proven to be effective

Diabetic Kidney

Disease

Non diabetic

Kidney disease

Kidney disease

In the transplant

Strict giycemic

control

 Yes * I:80-120

II:100-140

HbA1C(%):<7

NA Not tested

ACE  – inhibitors or 

angletensin-receptor blockers

 Yes Yes

(greater affect in patients withproteinuria)

Not tested

Strict blood pressure

control

 Yes

< 125/75 mm

Hg

 Yes

<130/80 mm Hg

(greater affect in patients with

proteinuria)

<125/75 mm Hg(greater affect in patients with

proteinuria)

Not tested

* Prevents or delays the onset of diabetic kidney discase.

Page 8: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 8/19

Should be referred to nephrologist

• Most cases of nonprogressive chronic kidney disease can bemanaged without referral to a nephrologist.

• Referral to a nephrologist is recommended :

- patients with acute kidney failure

- GFR less than 30 mL/min/1.73 m2

- progressive decline of kidney function

- inability to achieve treatment targets

- urine albumin to creatinine ratio greater than 500

mg/24 h)

Guidelines for the management of chronic

kidney disease (Canadian Medical Association) 

Page 9: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 9/19

Late vs early referral

Page 10: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 10/19

• Pernefri,2005 : KK < 15 ml/min for DM, <10 ml/min for non DM. Earlier if uremicsymptoms persist.

• National Kidney Foundation (2006) estimated GFR ≤ 15.0 ml per minute

and ≥ 15.0 ml per minute when patients have coexisting conditions or

symptoms of uremia

• Canadian Society of Nephrology, 2008 → Patients with an estimated GFR <20 mL/min/m2 may require initiation of renal replacement therapy if any of 

clinical indicator are present:

- symptoms of uremia (after excluding other causes)

- refractory metabolic complications (hyperkalemia, acidosis)

- volume overload (manifesting as resistant edema or hypertension)

- decline in nutritional status (as measured by serum albumin, lean

body mass or Subjective Global Assessment) that is refractory to

dietary intervention .

Timing of initiation renal replacement therapy

Page 11: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 11/19

Level of GFR at initiation of replacement

therapy in US 

USRDS,1999

Data 2009 :

- eGFr  of ≥15 ml/min/1.73 m2 

increased from 4% to 17%

- eGFr  of ≥15 ml/min/1.73 m2 

increased from 4% to 17%

Page 12: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 12/19

Modality renal replacement therapy

(for chronic kidney disease)

• Kidney transplant

• Hemodialysis (HD)

•Continuos Ambulatory Peritoneal Dialysis(CAPD)

Page 13: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 13/19

kidney transplant 

Data resipien donor 

ABO/Rh o/+ o/+HLA A24(A9),A66/A10(?) A(11)?

Crossmatch ±20%, pasca imuran 2 mg : 20%HBsAg/Anti -/+ -/-

HSV1 IgG+/IgM+ IgG+/IgM-HSV2 IgG+/IgM+ IgG-/IgG-Anti CMV IgG+/IgM- IgG+/IgM-HCV -tive -tiveHIV -tive -tiveVDRL/TPHA -tive/-tive -teve/-tiveHb 9,1 12,3Lekosit 5.7 5.4Trombosit 186 300

Page 14: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 14/19

Hemodialysis

Page 15: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 15/19

6

7

8

1

Page 16: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 16/19

Preparation

of access for 

HD

Page 17: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 17/19

CAPD

Page 18: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 18/19

Preparation for CAPD

Page 19: Renal replacement therapy (kuliah S1 perawat).pptx

7/28/2019 Renal replacement therapy (kuliah S1 perawat).pptx

http://slidepdf.com/reader/full/renal-replacement-therapy-kuliah-s1-perawatpptx 19/19

Apa peranan perawat pada

penanganan pasien CKD ?

• Asuhan keperawatan pasien CKD

• Asuhan keperawatan pasien renalreplacement therapy (kidney

transplant,HD,CAPD)• Perawat OK (operasi kidney

transplant,CAPD,akses HD)

• Perawat dialisis : melaksanakan HD, merawatkateter HD dan CAPD

• Edukasi pasien